Xeris Biopharma Holdings Inc. buy HC Wainwright
Start price
09.03.23
/
50%
€1.15
Target price
09.03.24
€5.67
Performance (%)
91.14%
End price
10.03.24
€2.20
Summary
This prediction ended on 10.03.24 with a price of €2.20. With a performance of 91.14% the BUY prediction by HC_Wainwright was a big success. HC_Wainwright has a follow-up prediction for Xeris Biopharma Holdings Inc. where he still thinks Xeris Biopharma Holdings Inc. is a Buy. HC_Wainwright has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Xeris Biopharma Holdings Inc. | -5.263% | -5.263% | -28.293% |
| iShares Core DAX® | -0.683% | 1.890% | 15.367% |
| iShares Nasdaq 100 | 0.335% | 4.631% | 29.818% |
| iShares Nikkei 225® | -1.486% | -2.361% | 7.668% |
| iShares S&P 500 | -0.523% | 2.324% | 25.460% |
Comments by HC_Wainwright for this prediction
In the thread Xeris Biopharma Holdings Inc. diskutieren
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Ratings data for XERS provided by MarketBeat
In the thread Trading Xeris Biopharma Holdings Inc.
Die von HC_Wainwright gewählte maximale Laufzeit wurde überschritten
Current prediction by HC_Wainwright for Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc.
Start price
Target price
Perf. (%)
€2.16
10.08.23
10.08.23
€5.44
10.08.24
10.08.24
-6.48%
16:22
16:22
